English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [9503]
News [23329]
Articles [1990]
Editorials [134]
Conferences [463]
elearning [298]
Current techniques in the treatment of lung cancer
Prof Jacek Jassem - University of Gdansk, Poland
Current techniques in the treatment of lung cancer ( Prof Jacek Jassem - University of Gdansk, Poland )
29 Jun 2010
The role of patient advocacy groups and the efforts being made to help improve...
Jan Geissler - European Cancer Patient Coalition
The role of patient advocacy groups and the efforts being made to help improve the spread and accessibility of information for patients ( Jan Geissler - European Cancer Patient Coalition )
25 Jun 2010
Tackling ageism in cancer treatment
Jan Geissler - European Cancer Patient Coalition
Tackling ageism in cancer treatment ( Jan Geissler - European Cancer Patient Coalition )
25 Jun 2010
Using oncopolicy to tackle issue of ageism in cancer treatment
Professor Richard Sullivan - King's College London, UK
Using oncopolicy to tackle issue of ageism in cancer treatment ( Professor Richard Sullivan - King's College London, UK )
25 Jun 2010
Results of the multiple myeloma study comparing zoledronic acid to clodronate
Prof Gareth Morgan - Institute of Cancer Research, Sutton, UK
Results of the multiple myeloma study comparing zoledronic acid to clodronate ( Prof Gareth Morgan - Institute of Cancer Research, Sutton, UK )
25 Jun 2010
Conatumumab or AMG 479 as treatment for pancreatic cancer
Prof Hedy Kindler - University of Chicago, USA
Conatumumab or AMG 479 as treatment for pancreatic cancer ( Prof Hedy Kindler - University of Chicago, USA )
25 Jun 2010
Progress in myeloma survival rates
Professor Jesús San-Miguel - University Hospital of Salamanca, Spain
Progress in myeloma survival rates ( Professor Jesús San-Miguel - University Hospital of Salamanca, Spain )
25 Jun 2010
NKTR-102: a new drug for treating platinum-resistant or refractory ovarian...
Professor Ignace Vergote - Catholic University of Leuven, Belgium
NKTR-102: a new drug for treating platinum-resistant or refractory ovarian cancer ( Professor Ignace Vergote - Catholic University of Leuven, Belgium )
25 Jun 2010
The efficacy of bendamustine and rituximab in the treatment of indolent...
Dr Mathias Rummel - University Hospital, Giessen, Germany
The efficacy of bendamustine and rituximab in the treatment of indolent lymphoma diseases ( Dr Mathias Rummel - University Hospital, Giessen, Germany )
25 Jun 2010
Breast cancers that spread to the liver may change biology, impacting treatment...
Dr Giuseppe Curigliano - European Institute of Oncology, Milan, Italy
Breast cancers that spread to the liver may change biology, impacting treatment effectiveness ( Dr Giuseppe Curigliano - European Institute of Oncology, Milan, Italy )
11 Jun 2010
Roundup of the 2010 ASCO conference
Prof Gordon McVie - European Institute of Oncology, Milan
Roundup of the 2010 ASCO conference ( Prof Gordon McVie - European Institute of Oncology, Milan )
11 Jun 2010
Antibody drug ipilimumab improves long-term survival in previously treated...
Dr Steven O'Day - The Angeles Clinic and Research Institute, Santa Monica...
Antibody drug ipilimumab improves long-term survival in previously treated advanced melanoma ( Dr Steven O'Day - The Angeles Clinic and Research Institute, Santa Monica, California )
11 Jun 2010
<1…755756757758759…792>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2026 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top